FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2308237686> ?p ?o ?g. }

• W2308237686 endingPage "896" @default.
• W2308237686 startingPage "889" @default.
• W2308237686 abstract "The kinase activity of mTOR involves 2 multiprotein complexes, (mTORC1-mTORC2). Targeting mTORC1 with rapalogues induces compensatory feedback loops resulting in AKT/ERK activation, which may be abrogated by mTORC2 inhibition. A first-in-human trial evaluating tolerability, pharmacokinetics and pharmacodynamics of the dual TORC1/TORC2 inhibitor OSI-027 was conducted.Dose escalation was pursued for three schedules of administration (three consecutive days per week (S1), once a week (S2) and daily dosing (S3)), until dose-limiting toxicities (DLT) were identified. Expansion cohorts with paired tumour biopsies were initiated based on tolerability and pharmacodynamics.One hundred and twenty eight patients with advanced cancer were enrolled. DLT consisted predominantly of fatigue, renal function disturbances and cardiac events. OSI-027 exposure was dose proportional, with Tmax within 4 h and a half-life of ∼14 h. Expansion cohorts were initiated for S1 and S2, as MTD for S3 was overall considered suboptimal. Target modulation in peripheral blood mononuclear cells were observed from 30 mg, but in tumour biopsies 120 mg QD were needed, which was a non-tolerable dose due to renal toxicity. No RECIST responses were recorded, with stable disease >6 months in six (5%) patients.OSI-027 inhibits mTORC1/2 in patients with advanced tumour s in a dose-dependent manner but doses above the tolerable levels in S1 and S3 are required for a sustained biological effect in tumour biopsies." @default.
• W2308237686 created "2016-06-24" @default.
• W2308237686 creator A5003515419 @default.
• W2308237686 creator A5013890164 @default.
• W2308237686 creator A5014671025 @default.
• W2308237686 creator A5014804968 @default.
• W2308237686 creator A5021550191 @default.
• W2308237686 creator A5026692589 @default.
• W2308237686 creator A5032324017 @default.
• W2308237686 creator A5048013245 @default.
• W2308237686 creator A5049719185 @default.
• W2308237686 creator A5059456039 @default.
• W2308237686 creator A5064026461 @default.
• W2308237686 creator A5064953304 @default.
• W2308237686 creator A5072116005 @default.
• W2308237686 creator A5088744286 @default.
• W2308237686 date "2016-03-22" @default.
• W2308237686 modified "2023-10-14" @default.
• W2308237686 title "A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies" @default.
• W2308237686 cites W1967639975 @default.
• W2308237686 cites W1998752234 @default.
• W2308237686 cites W2024104654 @default.
• W2308237686 cites W2035240798 @default.
• W2308237686 cites W2035521247 @default.
• W2308237686 cites W2045154939 @default.
• W2308237686 cites W2055328142 @default.
• W2308237686 cites W2060157525 @default.
• W2308237686 cites W2081985260 @default.
• W2308237686 cites W2089413248 @default.
• W2308237686 cites W2115686439 @default.
• W2308237686 cites W2116622644 @default.
• W2308237686 cites W2118677643 @default.
• W2308237686 cites W2130127620 @default.
• W2308237686 cites W2139248078 @default.
• W2308237686 cites W2147221492 @default.
• W2308237686 cites W2149218373 @default.
• W2308237686 cites W2152289580 @default.
• W2308237686 cites W2153867442 @default.
• W2308237686 cites W2161295623 @default.
• W2308237686 cites W2165534057 @default.
• W2308237686 cites W2167188058 @default.
• W2308237686 cites W2303830728 @default.
• W2308237686 cites W2319833803 @default.
• W2308237686 doi "https://doi.org/10.1038/bjc.2016.59" @default.
• W2308237686 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4984800" @default.
• W2308237686 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27002938" @default.
• W2308237686 hasPublicationYear "2016" @default.
• W2308237686 type Work @default.
• W2308237686 sameAs 2308237686 @default.
• W2308237686 citedByCount "42" @default.
• W2308237686 countsByYear W23082376862016 @default.
• W2308237686 countsByYear W23082376862017 @default.
• W2308237686 countsByYear W23082376862018 @default.
• W2308237686 countsByYear W23082376862019 @default.
• W2308237686 countsByYear W23082376862020 @default.
• W2308237686 countsByYear W23082376862021 @default.
• W2308237686 countsByYear W23082376862022 @default.
• W2308237686 countsByYear W23082376862023 @default.
• W2308237686 crossrefType "journal-article" @default.
• W2308237686 hasAuthorship W2308237686A5003515419 @default.
• W2308237686 hasAuthorship W2308237686A5013890164 @default.
• W2308237686 hasAuthorship W2308237686A5014671025 @default.
• W2308237686 hasAuthorship W2308237686A5014804968 @default.
• W2308237686 hasAuthorship W2308237686A5021550191 @default.
• W2308237686 hasAuthorship W2308237686A5026692589 @default.
• W2308237686 hasAuthorship W2308237686A5032324017 @default.
• W2308237686 hasAuthorship W2308237686A5048013245 @default.
• W2308237686 hasAuthorship W2308237686A5049719185 @default.
• W2308237686 hasAuthorship W2308237686A5059456039 @default.
• W2308237686 hasAuthorship W2308237686A5064026461 @default.
• W2308237686 hasAuthorship W2308237686A5064953304 @default.
• W2308237686 hasAuthorship W2308237686A5072116005 @default.
• W2308237686 hasAuthorship W2308237686A5088744286 @default.
• W2308237686 hasBestOaLocation W23082376861 @default.
• W2308237686 hasConcept C107846503 @default.
• W2308237686 hasConcept C111113717 @default.
• W2308237686 hasConcept C112705442 @default.
• W2308237686 hasConcept C126322002 @default.
• W2308237686 hasConcept C143998085 @default.
• W2308237686 hasConcept C197934379 @default.
• W2308237686 hasConcept C2777288759 @default.
• W2308237686 hasConcept C2778375690 @default.
• W2308237686 hasConcept C55493867 @default.
• W2308237686 hasConcept C62478195 @default.
• W2308237686 hasConcept C71924100 @default.
• W2308237686 hasConcept C86554907 @default.
• W2308237686 hasConcept C86803240 @default.
• W2308237686 hasConcept C98274493 @default.
• W2308237686 hasConcept C98490376 @default.
• W2308237686 hasConceptScore W2308237686C107846503 @default.
• W2308237686 hasConceptScore W2308237686C111113717 @default.
• W2308237686 hasConceptScore W2308237686C112705442 @default.
• W2308237686 hasConceptScore W2308237686C126322002 @default.
• W2308237686 hasConceptScore W2308237686C143998085 @default.
• W2308237686 hasConceptScore W2308237686C197934379 @default.
• W2308237686 hasConceptScore W2308237686C2777288759 @default.
• W2308237686 hasConceptScore W2308237686C2778375690 @default.
• W2308237686 hasConceptScore W2308237686C55493867 @default.

• next